Literature DB >> 18759058

Parvovirus 4 (PARV4) in serum of intravenous drug users and blood donors.

W Lurcharchaiwong, T Chieochansin, S Payungporn, A Theamboonlers, Y Poovorawan.   

Abstract

Mesh：

Year:  2008        PMID： 18759058     DOI： 10.1007/s15010-008-7336-4

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  21 in total

Review 1.  Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Gabriele Calizzani; Fabio Candura; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-04       Impact factor: 3.443

Review 2.  Beyond Cytomegalovirus and Epstein-Barr Virus: a Review of Viruses Composing the Blood Virome of Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.

Authors:  Marie-Céline Zanella; Samuel Cordey; Laurent Kaiser
Journal:  Clin Microbiol Rev       Date:  2020-08-26       Impact factor: 26.132

3.  Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter?

Authors:  Eric Delwart
Journal:  Transfusion       Date:  2012-07       Impact factor: 3.157

4.  Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild.

Authors:  Colin P Sharp; Matthew LeBreton; Kalle Kantola; Ahmadou Nana; Joseph Le Doux Diffo; Cyrille F Djoko; Ubald Tamoufe; John A Kiyang; Tafon G Babila; Eitel Mpoudi Ngole; Oliver G Pybus; Eric Delwart; Eric Delaporte; Martine Peeters; Maria Soderlund-Venermo; Klaus Hedman; Nathan D Wolfe; Peter Simmonds
Journal:  J Virol       Date:  2010-07-28       Impact factor: 5.103

5.  High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.

Authors:  Colin P Sharp; Alice Lail; Sharyne Donfield; Ruth Simmons; Clifford Leen; Paul Klenerman; Eric Delwart; Edward D Gomperts; Peter Simmonds
Journal:  J Infect Dis       Date:  2009-10-01       Impact factor: 5.226

6.  Human parvovirus 4 in nasal and fecal specimens from children, Ghana.

Authors:  Jan Felix Drexler; Ulrike Reber; Doreen Muth; Petra Herzog; Augustina Annan; Fabian Ebach; Nimarko Sarpong; Samuel Acquah; Julia Adlkofer; Yaw Adu-Sarkodie; Marcus Panning; Egbert Tannich; Jürgen May; Christian Drosten; Anna Maria Eis-Hübinger
Journal:  Emerg Infect Dis       Date:  2012-10       Impact factor: 6.883

7.  No evidence of presence of parvovirus 4 in a Swedish cohort of severely immunocompromised children and adults.

Authors:  Thomas Tolfvenstam; Oscar Norbeck; Lars Ohrmalm
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

8.  Parvovirus 4 infection and clinical outcome in high-risk populations.

Authors:  Ruth Simmons; Colin Sharp; C Patrick McClure; Janine Rohrbach; Helen Kovari; Eleni Frangou; Peter Simmonds; Will Irving; Andri Rauch; Paul Bowness; Paul Klenerman
Journal:  J Infect Dis       Date:  2012-04-05       Impact factor: 5.226

9.  Parvovirus 4 in blood donors, France.

Authors:  Mhammed Touinssi; Nadège Brisbarre; Christophe Picard; Coralie Frassati; Bertrand Dussol; Rathviro Uch; Pierre Gallian; Jean-François Cantaloube; Philippe de Micco; Philippe Biagini
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

10.  Evolution of CD8+ T cell responses after acute PARV4 infection.

Authors:  Ruth Simmons; Colin Sharp; Jordana Levine; Paul Bowness; Peter Simmonds; Andrea Cox; Paul Klenerman
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.